ArticleProstate cancer and prostatic diseases2018

Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer.

Karthik V Giridhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.